Notably, the activation of immune checkpoint pathways, such as PD-1/PD-L1 and CTLA-4, enables tumor cells to suppress T cell-mediated anti-tumor responses, thereby supporting their survival (3, 4). The gene discussed is CTLA4; the disease is neoplasm.